Analystreport

United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $237.00 price target on the stock.

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations